ReviewTranslational lung cancer research2020

Is there any place for immune-checkpoint inhibitors in the treatment algorithm of fusion-driven non-small cell lung cancer?-a literature review.

Gianmarco Leone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.